Association of Activated Clotting Time–Guided Anticoagulation with Complications during Extracorporeal Membrane Oxygenation Support: A Systematic Review and Meta-Analysis
Journal of Cardiothoracic and Vascular Anesthesia · 2024-12 · 38 (12) · 3034-3042
DOI: 10.1053/j.jvca.2024.09.003 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Cardiothoracic and Vascular Anesthesia, 2024-12. Verfasst von Daniel Schwaiger und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology and Critical Care Medicine, Medical University of Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Anticoagulants. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
OBJECTIVE: Extracorporeal membrane oxygenation (ECMO) requires systemic anticoagulation to reduce the risk of thromboembolic events. Despite its historic role, activated clotting time (ACT) remains a widely used heparin monitoring method. Systematic evidence on the association of ACT-guided monitoring with hemorrhagic or thromboembolic complications does not exist. DESIGN: Systematic literature review and meta-analysis (Scopus and PubMed, July 2023). SETTING: All cohort studies. PARTICIPANTS: Patients receiving ECMO support. INTERVENTION: Anticoagulation monitoring with ACT. MEASUREMENTS AND MAIN RESULTS: We identified 3,177 publications, with 8 studies reporting the average ACT values for patients with and without bleeding. Meta-analysis revealed no significant difference in the compared groups (SMD = 0.69; 95% CI -0.05 to 1.43, p = 0.069; I2 = 87.4%). Three studies (n = 117 patients) reported on the average ACT values for patients with thrombosis, without significant differences in ACT between patients with and without thrombosis (SMD = 0.47; 95% CI -0.50 to 1.44, p = 0.342; I2 = 81.1%). CONCLUSIONS: Even though ACT is a widely used heparin monitoring tool, the evidence on its association with hemorrhagic or thromboembolic events is still controversial and limited. Further studies are essential to elucidate the role of ACT in anticoagulation monitoring during ECMO support.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesiology and Critical Care Medicine, Medical University of Innsbruck, Innsbruck, Austria.
- Anaesthesia and Intensive Care Department, Pain Therapy Service, Cagliari University, Cagliari, Italy.
- Institute of Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
- Department of Anaesthesiology and Critical Care Medicine, Medical University of Innsbruck, Innsbruck, Austria. Electronic address: sasa.rajsic@i-med.ac.at.
Zitieren
APA
Schwaiger, D., Schausberger, L., Treml, B., Jadzic, D., Innerhofer, N., Oberleitner, C., Bukumiric, Z., & Rajsic, S. (2024). Association of Activated Clotting Time–Guided Anticoagulation with Complications during Extracorporeal Membrane Oxygenation Support: A Systematic Review and Meta-Analysis. Journal of Cardiothoracic and Vascular Anesthesia, 38(12), 3034-3042. https://doi.org/10.1053/j.jvca.2024.09.003
Vancouver
Schwaiger D, Schausberger L, Treml B, Jadzic D, Innerhofer N, Oberleitner C, et al. Association of Activated Clotting Time–Guided Anticoagulation with Complications during Extracorporeal Membrane Oxygenation Support: A Systematic Review and Meta-Analysis. Journal of Cardiothoracic and Vascular Anesthesia. 2024;38(12):3034-3042. doi:10.1053/j.jvca.2024.09.003
BibTeX
@article{Schwaiger2024,
author = {Schwaiger, Daniel and Schausberger, Lukas and Treml, Benedikt and Jadzic, Dragana and Innerhofer, Nicole and Oberleitner, Christoph and Bukumiric, Zoran and Rajsic, Sasa},
title = {Association of Activated Clotting Time–Guided Anticoagulation with Complications during Extracorporeal Membrane Oxygenation Support: A Systematic Review and Meta-Analysis},
journal = {Journal of Cardiothoracic and Vascular Anesthesia},
year = {2024},
volume = {38},
number = {12},
pages = {3034--3042},
doi = {10.1053/j.jvca.2024.09.003}
}
EUVIMED